Reproductive Health Science (RHS)
RHS Ltd. engages in the research, development, and commercialization of biotechnology products. It offers EmbryoCellect microarray technology and DOPlify whole genome amplification. The company was founded on March 21, 1980 and is headquartered in Thebarton, Australia.
|Market Price at 13-12-2017||$0.15|
|Price to Earnings Ratio||-1.17|
|Market Capitalisation||$13.04 (million)|
|Return on Equity (ROE)||-341.95%|